Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy

por Lingvay, Ildiko, Greenberg, Michelle, Gallo, Silvina, Shi, Harry, Liu, Jie, Gantz, Ira
Publicado 2021

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis

por McGuire, Darren K., Shih, Weichung J., Cosentino, Francesco, Charbonnel, Bernard, Cherney, David Z. I., Dagogo-Jack, Samuel, Pratley, Richard, Greenberg, Michelle, Wang, Shuai, Huyck, Susan, Gantz, Ira, Terra, Steven G., Masiukiewicz, Urszula, Cannon, Christopher P.
Publicado 2020